DNA production specialist Touchlight raises £42m
11th March 2021
Hampton, UK-based biotech company Touchlight has raised £42m in its latest fundraising round, led by Bridford Investments Limited.
Touchlight is focused on enzymatic DNA production to enable the manufacturing of genetic medicine, including DNA and mRNA vaccines in addition to cell and gene therapies.
The new funding will allow the company to ‘more than triple’ its manufacturing footprint and also increase capacity to up to 1kg GMP DNA per month in Q1 2022.
Touchlight has developed a unique synthetic DNA vector – called dbDNA or ‘doggybone DNA’ – which it says has advantages over traditional plasmid DNA (pDNA) manufacturing.